Estradiol

Estradiol, a form of estrogen, is a hormone present in both men and women, playing vital roles in reproductive health, bone density, mood regulation, and cardiovascular function. While predominantly associated with female biology due to its higher concentrations and key roles in female reproductive functions and characteristics, estradiol also contributes to important physiological processes in men, including fertility, libido, and bone health.

Human scalp hair follicles carry estrogen receptors, mainly estrogen receptor beta (Thornton et al., 2003), so estrogen can influence the hair cycle. How much this matters for hair loss in people is not clear. Estradiol is not a treatment for chemotherapy-related hair loss. People with breast, uterine or other hormone-sensitive cancer must not use estrogen in any form unless their oncologist approves.

Evidence in people is limited. In a randomised trial in 103 women with pattern hair loss, hair density and thickness remained nearly unchanged after six months of topical 17α-estradiol (alfatradiol), while minoxidil improved both; the authors credited alfatradiol only with slowing or stabilizing hair loss, but the trial had no placebo group, so it could not show that alfatradiol slowed hair loss (Blume-Peytavi et al., 2007). In a 2025 randomised trial in 43 women, adding a topical estrogen to minoxidil gave no statistically significant advantage over minoxidil alone, and more women had menstrual irregularities (Bedair et al., 2025). One case report describes scalp hair regrowth in a transgender woman after about six months of oral estradiol and spironolactone (Stevenson et al., 2016).

Estradiol is a prescription hormone and is not approved for hair loss. US estrogen labels carry a boxed warning for endometrial cancer, heart attack, stroke, blood clots, breast cancer and probable dementia. The label says estrogen must not be used by people with known, suspected or past breast cancer or other estrogen-dependent cancer, or a history of blood clots (estradiol prescribing information, DailyMed). Estradiol gels and sprays can pass to children and pets through skin contact (FDA, 2010). Estradiol is not a hair-loss treatment for men: in men it causes breast growth and other feminizing changes, some of which may not reverse, and it can reduce fertility.

Users of estradiol have a wide range of viewpoints regarding the role of estradiol in hair loss treatment. Transgender individuals, for example, have shared their journeys with estradiol as part of broader hormone therapy regimens, noting its impact on hair regrowth alongside other treatments such as minoxidil and spironolactone. Conversations around alfatradiol, another form of estradiol, reveal mixed results, highlighting the ongoing need for research into its dosage and efficacy. Members of the community have also voiced concerns over potential side effects, including elevated estradiol levels and gynecomastia, particularly when estradiol is used in conjunction with other hair loss treatments.

Sources: Thornton MJ et al. Exp Dermatol 2003 (PMID 12702147); Blume-Peytavi U et al. J Dtsch Dermatol Ges 2007 (PMID 17451383); Bedair NI et al. Clin Exp Dermatol 2025 (PMID 39412172); Stevenson MO et al. Transgend Health 2016 (PMID 28861534); estradiol tablets prescribing information, DailyMed (https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5718f042-e8c0-b721-e063-6294a90a5bef); FDA Drug Safety Communication on Evamist and unintended exposure of children and pets to topical estrogen, 29 July 2010.